Autopsy report · NCT01735916
MIRACLE EF Clinical Study
Cause of deathSlow enrollment
“The study was terminated early due to low enrollment.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 3 months before it stopped.
- 44 participants enrolled.
- Results were posted on the registry 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Sponsor type
- Industry
- Conditions
- Congestive Heart Failure; Left Bundle Branch Block; Systolic Heart Failure
- Interventions
- CRT-P Implant; CRT-P OFF
- Participants
- 44
- Sites
- 73
- Countries
- India, Russia, Sweden, United Kingdom, United States
Trials that died the same way
- A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
“Due to low enrollment, this study was terminated early.” - Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
“Study was terminated early due to low enrollment numbers.” - A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
“This study was terminated early due to poor enrollment.” - A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
“The study was terminated due to low enrollment.” - Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
“the study was terminated early due to poor enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.